Revvity Inc. (RVTY)
NYSE · Healthcare · Diagnostics & Research
Revvity Inc. is a Healthcare company with a market capitalization of $12.61B, a trailing P/E ratio of 54.3, and a dividend yield of 0.25%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 5, 2026 | $1.06 | $1.01 | +5.0% |
| Q4 2025 | February 2, 2026 | $0.87 | $0.85 | +2.4% |
| Q3 2025 | October 27, 2025 | $0.40 | $0.50 | -20.0% |
| Q2 2025 | July 28, 2025 | $1.18 | $1.14 | +3.5% |
| Q1 2025 | April 28, 2025 | $1.01 | $0.95 | +6.3% |
| Q4 2024 | January 31, 2025 | $1.42 | $1.38 | +2.9% |
Other Diagnostics & Research Stocks
Frequently Asked Questions
What is Revvity Inc.'s market cap?
As of June 29, 2026, Revvity Inc. (RVTY) has a market capitalization of $12.61B.
What is Revvity Inc.'s P/E ratio?
Revvity Inc. trades at a trailing price-to-earnings (P/E) ratio of 54.3. Its forward P/E is 20.9.
Does Revvity Inc. pay a dividend?
Yes — Revvity Inc. pays a dividend yielding 0.25%, an annual payout of $0.28 per share.
What sector is RVTY in?
Revvity Inc. is in the Healthcare sector, specifically the Diagnostics & Research industry.
What was Revvity Inc.'s revenue?
In its latest reported fiscal year (ending December 31, 2025), Revvity Inc. reported revenue of $2.86B and net income of $241.68M.
Ask your own questions about RVTY
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.